Kinnate Biopharma, Inc.
(NASDAQ : KNTE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.07%171.790.7%$1114.12m
AZNAstraZeneca Plc 0.47%58.231.0%$926.89m
PFEPfizer Inc. 0.60%41.720.9%$889.74m
MRKMerck & Co., Inc. 1.36%77.570.7%$779.19m
LLYEli Lilly & Co. 2.47%244.381.1%$746.72m
ABBVAbbVie, Inc. 0.50%118.131.9%$709.77m
BMYBristol-Myers Squibb Co. 0.50%68.301.0%$595.22m
NRXPNRX Pharmaceuticals, Inc. 50.58%24.770.0%$217.95m
GSKGlaxoSmithKline Plc 0.74%39.520.2%$168.81m
CERECerevel Therapeutics Holdings, Inc. -1.28%24.670.2%$150.46m
NVSNovartis AG 0.57%91.600.2%$149.70m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 2.88%126.460.0%$93.07m
VTRSViatris, Inc. 0.51%13.920.0%$86.53m
OGNOrganon & Co. -3.66%29.790.0%$80.48m
ANVSAnnovis Bio, Inc. 12.03%120.000.0%$76.82m

Company Profile

Kinnate Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA.